olaparib,177lu-psma-617
astrazeneca,merck,novartis
['olaparib', 'luparp', 'crpc', '177lu,psma,617', 'psma-617 ']
circulating tumor cells in patients with #mcrpc treated with olaparib + 177lu-psma-617 in the #luparp trial. presentation by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology